WASHINGTON — August 1, 2025:
In a bold move to address America’s long-standing struggle with high prescription drug costs, former U.S. President Donald Trump has warned pharmaceutical companies of potential punitive actions if they fail to lower their prices.
Taking to his platform, Truth Social, Trump published letters addressed to 17 major pharmaceutical firms, urging them to collaborate with his administration and implement pricing reforms within 60 days. “If you refuse to cooperate, we will not hesitate to use every authority at our disposal to protect American families from this ongoing pricing corruption,” he wrote.
This latest development follows Trump’s signing of an executive order back in May aimed at curbing drug costs across the country — a signature issue he’s now doubling down on.
Trump stressed that the price of medication in the U.S. should align more closely with what consumers pay in other developed nations. If that doesn’t happen, he warned, tariffs on pharmaceutical imports could be imposed.
In the same speech, Trump also took aim at Canada, issuing a pointed remark following its recent stance on the Palestinian state. “I love Canada. I have many friends there,” he said. “But they’ll be treated the same way they treat us. I wasn’t happy with what they did.”
While Trump clarified that Canada’s recognition of a Palestinian state wasn’t a “deal breaker,” he hinted that it could influence future trade decisions. He noted that several new trade agreements have recently been finalized, suggesting shifting dynamics in international partnerships.
Trump’s message, delivered with characteristic bluntness, is likely to reignite debates around healthcare, international diplomacy, and the economic consequences of U.S. foreign policy decisions.
